Palatin Technologies
PTN
#10980
Rank
ยฃ6.63 M
Marketcap
ยฃ3.72
Share price
-0.20%
Change (1 day)
N/A
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2026 (TTM): -ยฃ4.62 Million

According to Palatin Technologies's latest financial reports the company's current earnings are ยฃ12.88 Million. In 2025 the company made an earning of -ยฃ7.18 Million, an increase over its 2024 earnings that were of -ยฃ20.11 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ4.62 Million-35.71%
2025 -ยฃ7.18 Million-64.29%
2024 -ยฃ20.11 Million-16.9%
2023 -ยฃ24.19 Million5.99%
2022 -ยฃ22.83 Million-13.7%
2021 -ยฃ26.45 Million33.25%
2020 -ยฃ19.85 Million-172.11%
2019 ยฃ27.52 M2352.33%
2018 ยฃ1.12 M-94.13%
2017 ยฃ19.12 M-154.92%
2016 -ยฃ34.82 Million3.67%
2015 -ยฃ33.59 Million878%
2014 -ยฃ3.44 Million-72.64%
2013 -ยฃ12.56 Million-33.11%
2012 -ยฃ18.77 Million77.71%
2011 -ยฃ10.56 Million
2003 -ยฃ17.89 Million29.93%
2002 -ยฃ13.77 Million36.18%
2001 -ยฃ10.11 Million
1999 -ยฃ8.39 Million6.04%
1998 -ยฃ7.91 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.55 B-419,974.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ10.69 B-229,711.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
ยฃ0.61 B-13,209.87%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-ยฃ8.02 Million 72.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ0.18 B-4,011.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-ยฃ87.8 Million 1,784.89%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
ยฃ0.10 B-2,384.53%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-ยฃ22.01 Million 372.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-ยฃ41.4 Million 788.76%๐Ÿ‡บ๐Ÿ‡ธ USA